RBC Capital Maintains Sector Perform on ResMed, Raises Price Target to $206
Portfolio Pulse from Benzinga Newsdesk
RBC Capital analyst Craig Wong-Pan maintains a Sector Perform rating on ResMed (NYSE:RMD) and raises the price target from $204 to $206.
August 02, 2024 | 8:46 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
RBC Capital analyst Craig Wong-Pan maintains a Sector Perform rating on ResMed and raises the price target from $204 to $206.
The raised price target from $204 to $206 indicates a slightly more positive outlook on ResMed's stock, which could lead to a minor positive impact on the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100